Ireland vs Mauritius: Cause of death, by non-communicable diseases, female
Ireland
81.6%
in 2021
Mauritius
82.6%
in 2021
Ireland rank
29th
Mauritius rank
27th
Cause of death, by non-communicable diseases, female over time
- Ireland
- Mauritius
How they compare
Mauritius currently reports 82.6% against 81.6% in Ireland, a difference of 1.0%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Mauritius ahead.
Ireland ranks 29th and Mauritius ranks 27th of 185 countries.
Across the 3 decades both report, Ireland averaged higher in 1 and Mauritius in 2.
Head to head by decade
| Decade | Ireland | Mauritius | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 85.6% | 87.7% | 2.1% | Mauritius |
| 2010s | 90.3% | 88.0% | 2.3% | Ireland |
| 2020s | 84.0% | 85.6% | 1.6% | Mauritius |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, female, Ireland or Mauritius?
- Mauritius, at 82.6% against 81.6% in Ireland as of 2021.
- What is the difference in cause of death, by non-communicable diseases, female between Ireland and Mauritius?
- 1.0%, with Mauritius ahead.
- How many years of comparable data are there for Ireland and Mauritius?
- 6 years are reported by both, from 2000 to 2021.
- How do Ireland and Mauritius rank globally for cause of death, by non-communicable diseases, female?
- Ireland ranks 29th and Mauritius ranks 27th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, female (% of total female deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths due to non-communicable diseases divided by number of all female deaths, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.